89 related articles for article (PubMed ID: 18836117)
21. Optimising the management of anaemia in patients with cancer with practice guidelines using erythropoiesis-stimulating proteins.
Smyth D; Zumbrink S
Eur J Oncol Nurs; 2005; 9 Suppl 1():S3-S13. PubMed ID: 16202653
[TBL] [Abstract][Full Text] [Related]
22. Erythropoiesis-stimulating agents in patients with cancer: update on safety issues.
Pirker R
Expert Opin Drug Saf; 2009 Sep; 8(5):515-22. PubMed ID: 19637988
[TBL] [Abstract][Full Text] [Related]
23. Inflammation and resistance to erythropoiesis-stimulating agents--what do we know and what needs to be clarified?
Smrzova J; Balla J; Bárány P
Nephrol Dial Transplant; 2005 Sep; 20 Suppl 8():viii2-7. PubMed ID: 16079326
[TBL] [Abstract][Full Text] [Related]
24. [Risk assessment of recurrence of venous thromboembolism].
Lindhoff-Last E
Hamostaseologie; 2011 Feb; 31(1):7-12; quiz 13. PubMed ID: 21152680
[TBL] [Abstract][Full Text] [Related]
25. Incidence of venous thromboembolism in patients hospitalized with cancer.
Stein PD; Beemath A; Meyers FA; Skaf E; Sanchez J; Olson RE
Am J Med; 2006 Jan; 119(1):60-8. PubMed ID: 16431186
[TBL] [Abstract][Full Text] [Related]
26. The role of the pharmacist in optimizing the use of erythropoietin stimulating agents.
Gebara SN; Moubayed H
J Oncol Pharm Pract; 2010 Mar; 16(1):33-7. PubMed ID: 19401308
[TBL] [Abstract][Full Text] [Related]
27. Effect of reimbursement changes on erythropoiesis-stimulating agent utilization and transfusions.
Hess G; Nordyke RJ; Hill J; Hulnick S
Am J Hematol; 2010 Nov; 85(11):838-43. PubMed ID: 20976794
[TBL] [Abstract][Full Text] [Related]
28. Coagulopathic complications in breast cancer.
Caine GJ; Stonelake PS; Rea D; Lip GY
Cancer; 2003 Oct; 98(8):1578-86. PubMed ID: 14534872
[TBL] [Abstract][Full Text] [Related]
29. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
Verso M; Agnelli G
J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
[TBL] [Abstract][Full Text] [Related]
30. Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.
Samaras AT; Bennett CL
Am J Hematol Oncol; 2008 Aug; 7(8):327-332. PubMed ID: 21850277
[No Abstract] [Full Text] [Related]
31. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
32. Examining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic events.
Fandrey J; Dicato M
Oncologist; 2009; 14 Suppl 1():34-42. PubMed ID: 19762515
[TBL] [Abstract][Full Text] [Related]
33. A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry.
Steinmetz T; Totzke U; Schweigert M; Mittermüller J; Nawka S; Tesch H; Groschek M; Söling U; Hellebrand E; Tsamaloukas A
Eur J Cancer Care (Engl); 2011 Jul; 20(4):493-502. PubMed ID: 21029222
[TBL] [Abstract][Full Text] [Related]
34. Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated.
Katodritou E; Zervas K; Terpos E; Brugnara C
Br J Haematol; 2008 Jul; 142(1):3-10. PubMed ID: 18430192
[TBL] [Abstract][Full Text] [Related]
35. The link between cancer and venous thromboembolism: a review.
Kessler CM
Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S3-7. PubMed ID: 19654481
[TBL] [Abstract][Full Text] [Related]
36. Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome.
Mason DP; Quader MA; Blackstone EH; Rajeswaran J; DeCamp MM; Murthy SC; Quader AK; Rice TW
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):711-8. PubMed ID: 16515928
[TBL] [Abstract][Full Text] [Related]
37. Stimulating erythropoiesis: future perspectives.
Mikhail A; Covic A; Goldsmith D
Kidney Blood Press Res; 2008; 31(4):234-46. PubMed ID: 18587242
[TBL] [Abstract][Full Text] [Related]
38. Role of anticoagulation in the management of pancreatic cancer.
Sohail MA; Saif MW
JOP; 2009 Mar; 10(2):82-7. PubMed ID: 19287098
[TBL] [Abstract][Full Text] [Related]
39. [Anaemia, iron, transfusion and therapeutic alternatives. A review from a surgical perspective].
González ZM; Barrasa AG; Renau AR
Cir Esp; 2010 Dec; 88(6):358-68. PubMed ID: 20462573
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological prophylaxis of venous thromboembolism in contemporary radical retropubic prostatectomy: does concomitant pelvic lymphadenectomy matter?
Jessie BC; Marshall FF
Int J Urol; 2008 Oct; 15(11):951-6. PubMed ID: 18775031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
